Skip to main content
. 2009 Oct 13;101(8):1469–1480. doi: 10.1038/sj.bjc.6605275

Figure 2.

Figure 2

Validation through immunohistochemical (IHC) and immunofluorescense (IF) assays of the expression results obtained for the MMP7 and CD133 genes. (A and B) BRCA1 ER-negative tumour over-expressing MMP7. (C and D) BRCA1 ER-positive tumour lacking MMP7 expression. (E and F) BRCA1 ER-negative tumour over-expressing CD133. (G and H) BRCA1 ER-positive tumour lacking CD133 expression.